
Remedy Robotics
ACTIVEUS medtech company developing the N1 robotic system for fully remote, AI-assisted robotic endovascular procedures. Founded in 2021, headquartered in San Francisco.
Remedy Robotics
Founded 2021 · San Francisco, United StatesRemedy Robotics, Inc. is a US medical technology (medtech) company founded in 2021 by David Bell and Jake Sganga, headquartered in San Francisco, California. The company develops the N1 System — a robotic platform for performing complete endovascular procedures end-to-end, from diagnosis to discharge, using remote control (teleoperation), AI-assisted automation, and real-time 3D imaging with image registration and 360° steerable catheters. The system is investigational and not available for commercial sale. In 2024 the company performed the first entirely robotic human neurointervention, and in 2025 the first entirely remote neurointervention (both in Toronto, in collaboration with Unity Health). In November 2026 the company raised $62M in a Series B round led by DCVC.
Founders
Domain of activity
3 areas · 4 technologies · 2 industries- Autonomous systems
- Embodied AI
- Computer Vision
- Robotics
- Computer vision
- Embodied AI
- Simulation
- Healthcare
- Robotics
Global presence
HQ San Francisco · 2 regionsScale & funding
founded 2021 · Series BProfile & metadata
4 classification · 2 external linksClassification
- Statusactive
- Development stageearly
- Listed onNo
- Organization typeRobotics company
External links